USANA Health Sciences, Inc. (NYSE:USNA) Short Interest Update

USANA Health Sciences, Inc. (NYSE:USNA) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 578,100 shares, an increase of 19.0% from the January 15th total of 485,900 shares. Currently, 5.2% of the company’s stock are sold short. Based on an average daily trading volume, of 113,600 shares, the days-to-cover ratio is currently 5.1 days.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on USNA shares. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday. DA Davidson raised their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd.

USANA Health Sciences Trading Up 0.4 %

USNA stock traded up $0.13 during midday trading on Monday, hitting $31.73. 134,987 shares of the company’s stock were exchanged, compared to its average volume of 123,145. USANA Health Sciences has a 12-month low of $30.13 and a 12-month high of $50.49. The firm has a 50 day moving average price of $34.42 and a 200-day moving average price of $37.06. The stock has a market capitalization of $604.74 million, a price-to-earnings ratio of 11.21, a price-to-earnings-growth ratio of 0.84 and a beta of 0.87.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently bought and sold shares of USNA. R Squared Ltd purchased a new stake in USANA Health Sciences during the 4th quarter worth approximately $28,000. Safe Harbor Fiduciary LLC bought a new stake in shares of USANA Health Sciences in the 3rd quarter valued at approximately $30,000. KBC Group NV increased its holdings in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after acquiring an additional 519 shares during the last quarter. KLP Kapitalforvaltning AS bought a new stake in shares of USANA Health Sciences in the 4th quarter valued at approximately $83,000. Finally, Quantbot Technologies LP bought a new stake in shares of USANA Health Sciences in the 4th quarter valued at approximately $132,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.